Category: "Treatment"

Severe depression: Vagus nerve stimulator improves lives

Severe depression: Vagus nerve stimulator improves lives

For people with treatment-resistant depression, adding vagus nerve stimulation to medication can drastically improve their quality of life, concludes a new study. People with severe depression may benefit from the neurostimulation technique ‘vagus nerve stimulation.’ The National Institute of Mental Health suggest that over 16 million people in the United States have had at least […]

Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines

Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines

The American Academy of Neurology (AAN) and the American Epilepsy Society (AES) have provided new recommended practice guidelines for the management of new-onset and treatment-resistant epilepsy with anti-epileptic drugs (AEDs).1,2 The new guidelines highlight the evidence supporting the use of lamotrigine, vigabatrin, levetiracetam, pregabalin, gabapentin, and zonisamide for reducing the frequency of seizures in new-onset […]

Stem cell discovery could aid in developing treatments to control epileptic convulsions

Stem cell discovery could aid in developing treatments to control epileptic convulsions

A new line of human stem cells shows promise for one day advancing treatment for epileptic seizures. As reported in STEM CELLS Translational Medicine (SCTM), the cells are designed to deliver adenosine – which calms down overexcited neurons and protects them from damage — to the central nervous system (CNS). The research was conducted by […]

Implantable Device Provides New Treatment Option for Epilepsy Patients

Implantable Device Provides New Treatment Option for Epilepsy Patients

Richard Pollitt was at the end of his rope after years of suffering regular seizures, with some lasting five minutes and preventing him from working and enjoying his favorite pastimes. Desperate for relief after medications did not work, Pollitt had a small battery-powered device implanted in his skull to control seizures. Now he rarely has […]

Phelan-McDermid Syndrome Treatment Commences Clinical Trial Recruitment

Phelan-McDermid Syndrome Treatment Commences Clinical Trial Recruitment

This week, AMO Pharma Limited announced the commencement of patient recruitment for an interventional study of AMO-01, an investigational Ras-ERK pathway inhibitor for the treatment of Phelan-McDermid syndrome (PMS).   “Treatment of Phelan-McDermid syndrome represents a significant area of unmet need in healthcare, and AMO Pharma is grateful to the research team at Mt. Sinai […]

RECENT NEWS